Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

PHASE4TerminatedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

October 31, 2008

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Photodynamic Therapy (PDT) with Visudyne (verteporfin)

DRUG

Macugen (pegaptanib sodium)

Trial Locations (1)

85704-5614

Retina Centers, P.C., Northwest Location, Tucson

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eyetech Pharmaceuticals

INDUSTRY